Study Evaluating 2 Dosing Regimens of TRU-015 in Rheumatoid Arthritis - Related Studies

Study Evaluating 2 Dosing Regimens of TRU-015 in Rheumatoid Arthritis

This study is currently recruiting participants.

Study NCT00634933. Last updated on September 17, 2008. Information provided by Wyeth

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Active Rheumatoid Arthritis

2	Additional conditions recognized in this trial
		Arthritis
		Arthritis, Rheumatoid

3	More general conditions related to this trial
		Autoimmune Diseases
		Connective Tissue Diseases
		Immune System Diseases
		Joint Diseases
		Musculoskeletal Diseases
		Rheumatic Diseases

4	Interventions listed in this trial
		TRU-015
		Placebo

5	Sponsors listed in this trial
		Wyeth
		Trubion Pharmaceuticals